A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found.

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...

An AI-based model for analyzing images appeared better able to predict ccRCC from CT-based images than a tumor size-based model was.

Researchers at NYU said that an experimental drug that blocks a key protein can trigger a form of self-destruction in lung ...

Using sophisticated RNA sequencing technology, biomedical researchers can measure the activity of our genes across millions ...

Researchers have developed the first bioengineered human bone-marrow model to test CAR T-cell therapies for ­acute myeloid ...

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...

New studies from Harvard and New York University reveal a way to disable a key protein that helps tumors survive.

Technology opens the door to more accurate preclinical testing, which could enable the development of safer and more effective therapies.